Your browser doesn't support javascript.
loading
Optimization of radotinib doses for the treatment of Asian patients with chronic myelogenous leukemia based on dose-response relationship analyses.
Noh, Hayeon; Park, Min Soo; Kim, Sung-Hyun; Oh, Suk Joong; Zang, Dae Young; Park, Hye Lin; Cho, Dae Jin; Kim, Dong-Wook; Lee, Jangik I.
Afiliación
  • Noh H; a Department of Pharmacy, College of Pharmacy , Yonsei University , Incheon , Republic of Korea ;
  • Park MS; b Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy , Yonsei University , Incheon , Republic of Korea ;
  • Kim SH; c Department of Pharmaceutical Medicine and Regulatory Science, Colleges of Medicine and Pharmacy , Yonsei University , Incheon , Republic of Korea ;
  • Oh SJ; d Department of Clinical Pharmacology, Severance Hospital , Yonsei University Health Systems , Seoul , Republic of Korea ;
  • Zang DY; e Department of Hematology and Oncology , Dong-A University Medical Center , Busan , Republic of Korea ;
  • Park HL; f Department of Internal Medicine, Kangbuk Samsung Hospital , Sungkyunkwan University School of Medicine , Seoul , Republic of Korea ;
  • Cho DJ; g Department of Internal Medicine , Hallym University Sacred Heart Hospital , Anyang , Republic of Korea ;
  • Kim DW; h Central Research Institute , IL-YANG Pharm. Co., Ltd. , Yongin , Republic of Korea ;
  • Lee JI; h Central Research Institute , IL-YANG Pharm. Co., Ltd. , Yongin , Republic of Korea ;
Leuk Lymphoma ; 57(8): 1856-64, 2016 08.
Article en En | MEDLINE | ID: mdl-26666371

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazinas / Benzamidas / Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Inhibidores de Proteínas Quinasas / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazinas / Benzamidas / Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Inhibidores de Proteínas Quinasas / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article